TNF and rheumatoid arthritis: In this meta-analysis of individual participant data from 3790 patients, the addition of certolizumab, a tumor necrosis factor α inhibitor, to conventional rheumatoid arthritis treatment was associated with an increased probability of reaching low disease activity in general.